Product News and Recalls

Medical groups voice concerns about transvaginal mesh implants

The American College of Obstetricians and Gynecologists and the American Urogynecologic Society recently issued a joint statement expressing the organizations’ concerns about the safety and effectiveness of transvaginal mesh implants to treat the condition pelvic organ prolapse.

In the statement, the groups say there’s an “urgent need” for a national registry to track outcomes for all current and future patients who get the procedure.

Pelvic organ prolapse occurs when there’s stretching or tearing of the pelvic floor muscles and connective tissue holding ...

continue reading...

Medical groups voice concerns about transvaginal mesh implants

The American College of Obstetricians and Gynecologists and the American Urogynecologic Society recently issued a joint statement expressing the organizations’ concerns about the safety and effectiveness of transvaginal mesh implants to treat the condition pelvic organ prolapse.

In the statement, the groups say there’s an “urgent need” for a national registry to track outcomes for all current and future patients who get the procedure.

Pelvic organ prolapse occurs when there’s stretching or tearing of the pelvic floor muscles and connective tissue holding ...

continue reading...

Report says Yaz, Yasmin big money-makers for Bayer

Shannon Pettypiece of Bloomberg Television provides some context for the recent national debates about birth control, pointing out that birth control constitutes “big business for big pharma.”

In a recent report, Ms. Pettypiece observed that Americans spent $5 billion last year for birth control. She said the German corporation Bayer gets about $1.5 billion a year from its drugs Yaz and Yasmin.

See the video here:

http://www.bloomberg.com/video/87718882/

Several studies show that Yaz, Yasmin, continue reading...

Yaz/Beyaz maker Bayer considering “significant” aquisition

Bayer, the German corporation that manufactures birth control pills Yaz, Beyaz and Yasmin, could finance a “significant” acquisition using a combination of debt, equity and its portfolio assets, Bloomberg reports.

Bloomberg cites an interview with Bayer’s Chief Financial Officer Werner Baumann, who said the company would only sell one of its three units “on the merits of its own strategic assessment.”

“You will not find us in a situation where we say we want to buy this, therefore we have to sell ...

continue reading...

British surgeons: Ban metal-on-metal hip joints

The British Hip Society, consisting of surgeons and scientists who work with the hip joint, has issued a recommendation that the use of metal-on-metal hip implants be discontinued because of their high early failure rate.

The Daily Telegraph quotes Joe Dias, president of the British Orthopaedic Association, as saying that about 5.5 percent of the large metal-on-metal implants – in which the ball and the socket are both coated with metal — needed to be replaced because of wear-and-tear within five ...

continue reading...

Frequent, long-term monitoring recommended for hip implants

According to an article in the New York Times, British health regulators are recommending that patients who received a certain type of metal-on-metal hip implant get annual examinations for as long as they have the devices, because of concerns that the implants will shed pieces of metallic debris as they wear.

Previously, the health regulators had recommended that the patients be monitored for five years. But recent data show the hip implants in question – consisting of both a ball and ...

continue reading...
Page 314 of 330 «...290300310312313314315316...»